Prevalence of Antibiotic Tolerance and Risk for Reinfection Among Escherichia coli Bloodstream Isolates: A Prospective Cohort Study
Abstract Background Tolerance is the ability of bacteria to survive transient exposure to high concentrations of a bactericidal antibiotic without a change in the minimal inhibitory concentration, thereby limiting the efficacy of antimicrobials. The study sought to determine the prevalence of tolera...
Gespeichert in:
Veröffentlicht in: | Clinical infectious diseases 2022-11, Vol.75 (10), p.1706-1713 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1713 |
---|---|
container_issue | 10 |
container_start_page | 1706 |
container_title | Clinical infectious diseases |
container_volume | 75 |
creator | Lazarovits, Gilad Gefen, Orit Cahanian, Noga Adler, Karen Fluss, Ronen Levin-Reisman, Irit Ronin, Irine Motro, Yair Moran-Gilad, Jacob Balaban, Nathalie Q Strahilevitz, Jacob |
description | Abstract
Background
Tolerance is the ability of bacteria to survive transient exposure to high concentrations of a bactericidal antibiotic without a change in the minimal inhibitory concentration, thereby limiting the efficacy of antimicrobials. The study sought to determine the prevalence of tolerance in a prospective cohort of E. coli bloodstream infection and to explore the association of tolerance with reinfection risk.
Methods
Tolerance, determined by the Tolerance Disk Test (TDtest), was tested in a prospective cohort of consecutive patient-unique E. coli bloodstream isolates and a collection of strains from patients who had recurrent blood cultures with E. coli (cohorts 1 and 2, respectively). Selected isolates were further analyzed using time-dependent killing and typed using whole-genome sequencing. Covariate data were retrieved from electronic medical records. The association between tolerance and reinfection was assessed by the Cox proportional-hazards regression and a Poisson regression models.
Results
In cohort 1, 8/94 isolates (8.5%) were tolerant. Using multivariate analysis, it was determined that the risk for reinfection in the patients with tolerant index bacteremia was significantly higher than for patients with a nontolerant strain, hazard ratio, 3.98 (95% confidence interval, 1.32–12.01). The prevalence of tolerance among cohort 2 was higher than in cohort 1, 6/21(28.6%) vs 8/94 (8.5%), respectively (P = .02).
Conclusions
Tolerant E. coli are frequently encountered among bloodstream isolates and are associated with an increased risk of reinfection. The TDtest appears to be a practicable approach for tolerance detection and could improve future patient management.
Tolerance may lead to the failure of antibiotic therapy. Applying the Tolerance Disk Test, we found that 8.5% of Escherichia coli bloodstream infections were tolerant, tolerant strains were more frequent among patients with recurrent bacteremia, and tolerance was an independent risk for reinfection. |
doi_str_mv | 10.1093/cid/ciac281 |
format | Article |
fullrecord | <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_cid_ciac281</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/cid/ciac281</oup_id><sourcerecordid>10.1093/cid/ciac281</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-fd0eee7b44d08ba4cdcedc2ed7fe8fc9a0bacaa186ee16c9971633eb344a7f783</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotn6cvEtOXmQ1afYj620tVQsFS63nJZtMbHR3syRpoWf_uFtaPXoYZhieeRkehK4ouaMkZ_fSqL6EHHF6hIY0YVmUJjk97meS8CjmjA_QmfefhFDKSXKKBiyJE0rIaIi-5w42ooZWArYaF20wlbHBSLy0NTix24tW4YXxX1hbhxdgWg0yGNviorHtB554uQJn5MoILG1t8GNtrfLBgWjw1NtaBPAPuMBzZ323O90AHtuVdQG_hbXaXqATLWoPl4d-jt6fJsvxSzR7fZ6Oi1kkWZKFSCsCAFkVx4rwSsRSSVByBCrTwLXMBamEFILyFICmMs8zmjIGFYtjkemMs3N0u8-V_SPegS47ZxrhtiUl5U5l2assDyp7-npPd-uqAfXH_rrrgZs9YNfdv0k_mXuBCA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Prevalence of Antibiotic Tolerance and Risk for Reinfection Among Escherichia coli Bloodstream Isolates: A Prospective Cohort Study</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Lazarovits, Gilad ; Gefen, Orit ; Cahanian, Noga ; Adler, Karen ; Fluss, Ronen ; Levin-Reisman, Irit ; Ronin, Irine ; Motro, Yair ; Moran-Gilad, Jacob ; Balaban, Nathalie Q ; Strahilevitz, Jacob</creator><creatorcontrib>Lazarovits, Gilad ; Gefen, Orit ; Cahanian, Noga ; Adler, Karen ; Fluss, Ronen ; Levin-Reisman, Irit ; Ronin, Irine ; Motro, Yair ; Moran-Gilad, Jacob ; Balaban, Nathalie Q ; Strahilevitz, Jacob</creatorcontrib><description>Abstract
Background
Tolerance is the ability of bacteria to survive transient exposure to high concentrations of a bactericidal antibiotic without a change in the minimal inhibitory concentration, thereby limiting the efficacy of antimicrobials. The study sought to determine the prevalence of tolerance in a prospective cohort of E. coli bloodstream infection and to explore the association of tolerance with reinfection risk.
Methods
Tolerance, determined by the Tolerance Disk Test (TDtest), was tested in a prospective cohort of consecutive patient-unique E. coli bloodstream isolates and a collection of strains from patients who had recurrent blood cultures with E. coli (cohorts 1 and 2, respectively). Selected isolates were further analyzed using time-dependent killing and typed using whole-genome sequencing. Covariate data were retrieved from electronic medical records. The association between tolerance and reinfection was assessed by the Cox proportional-hazards regression and a Poisson regression models.
Results
In cohort 1, 8/94 isolates (8.5%) were tolerant. Using multivariate analysis, it was determined that the risk for reinfection in the patients with tolerant index bacteremia was significantly higher than for patients with a nontolerant strain, hazard ratio, 3.98 (95% confidence interval, 1.32–12.01). The prevalence of tolerance among cohort 2 was higher than in cohort 1, 6/21(28.6%) vs 8/94 (8.5%), respectively (P = .02).
Conclusions
Tolerant E. coli are frequently encountered among bloodstream isolates and are associated with an increased risk of reinfection. The TDtest appears to be a practicable approach for tolerance detection and could improve future patient management.
Tolerance may lead to the failure of antibiotic therapy. Applying the Tolerance Disk Test, we found that 8.5% of Escherichia coli bloodstream infections were tolerant, tolerant strains were more frequent among patients with recurrent bacteremia, and tolerance was an independent risk for reinfection.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/cid/ciac281</identifier><identifier>PMID: 35451002</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Bacteremia - microbiology ; Escherichia coli ; Escherichia coli Infections - drug therapy ; Humans ; Prevalence ; Prospective Studies ; Reinfection</subject><ispartof>Clinical infectious diseases, 2022-11, Vol.75 (10), p.1706-1713</ispartof><rights>The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2022</rights><rights>The Author(s) 2022. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-fd0eee7b44d08ba4cdcedc2ed7fe8fc9a0bacaa186ee16c9971633eb344a7f783</citedby><cites>FETCH-LOGICAL-c357t-fd0eee7b44d08ba4cdcedc2ed7fe8fc9a0bacaa186ee16c9971633eb344a7f783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1578,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35451002$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lazarovits, Gilad</creatorcontrib><creatorcontrib>Gefen, Orit</creatorcontrib><creatorcontrib>Cahanian, Noga</creatorcontrib><creatorcontrib>Adler, Karen</creatorcontrib><creatorcontrib>Fluss, Ronen</creatorcontrib><creatorcontrib>Levin-Reisman, Irit</creatorcontrib><creatorcontrib>Ronin, Irine</creatorcontrib><creatorcontrib>Motro, Yair</creatorcontrib><creatorcontrib>Moran-Gilad, Jacob</creatorcontrib><creatorcontrib>Balaban, Nathalie Q</creatorcontrib><creatorcontrib>Strahilevitz, Jacob</creatorcontrib><title>Prevalence of Antibiotic Tolerance and Risk for Reinfection Among Escherichia coli Bloodstream Isolates: A Prospective Cohort Study</title><title>Clinical infectious diseases</title><addtitle>Clin Infect Dis</addtitle><description>Abstract
Background
Tolerance is the ability of bacteria to survive transient exposure to high concentrations of a bactericidal antibiotic without a change in the minimal inhibitory concentration, thereby limiting the efficacy of antimicrobials. The study sought to determine the prevalence of tolerance in a prospective cohort of E. coli bloodstream infection and to explore the association of tolerance with reinfection risk.
Methods
Tolerance, determined by the Tolerance Disk Test (TDtest), was tested in a prospective cohort of consecutive patient-unique E. coli bloodstream isolates and a collection of strains from patients who had recurrent blood cultures with E. coli (cohorts 1 and 2, respectively). Selected isolates were further analyzed using time-dependent killing and typed using whole-genome sequencing. Covariate data were retrieved from electronic medical records. The association between tolerance and reinfection was assessed by the Cox proportional-hazards regression and a Poisson regression models.
Results
In cohort 1, 8/94 isolates (8.5%) were tolerant. Using multivariate analysis, it was determined that the risk for reinfection in the patients with tolerant index bacteremia was significantly higher than for patients with a nontolerant strain, hazard ratio, 3.98 (95% confidence interval, 1.32–12.01). The prevalence of tolerance among cohort 2 was higher than in cohort 1, 6/21(28.6%) vs 8/94 (8.5%), respectively (P = .02).
Conclusions
Tolerant E. coli are frequently encountered among bloodstream isolates and are associated with an increased risk of reinfection. The TDtest appears to be a practicable approach for tolerance detection and could improve future patient management.
Tolerance may lead to the failure of antibiotic therapy. Applying the Tolerance Disk Test, we found that 8.5% of Escherichia coli bloodstream infections were tolerant, tolerant strains were more frequent among patients with recurrent bacteremia, and tolerance was an independent risk for reinfection.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Bacteremia - microbiology</subject><subject>Escherichia coli</subject><subject>Escherichia coli Infections - drug therapy</subject><subject>Humans</subject><subject>Prevalence</subject><subject>Prospective Studies</subject><subject>Reinfection</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotn6cvEtOXmQ1afYj620tVQsFS63nJZtMbHR3syRpoWf_uFtaPXoYZhieeRkehK4ouaMkZ_fSqL6EHHF6hIY0YVmUJjk97meS8CjmjA_QmfefhFDKSXKKBiyJE0rIaIi-5w42ooZWArYaF20wlbHBSLy0NTix24tW4YXxX1hbhxdgWg0yGNviorHtB554uQJn5MoILG1t8GNtrfLBgWjw1NtaBPAPuMBzZ323O90AHtuVdQG_hbXaXqATLWoPl4d-jt6fJsvxSzR7fZ6Oi1kkWZKFSCsCAFkVx4rwSsRSSVByBCrTwLXMBamEFILyFICmMs8zmjIGFYtjkemMs3N0u8-V_SPegS47ZxrhtiUl5U5l2assDyp7-npPd-uqAfXH_rrrgZs9YNfdv0k_mXuBCA</recordid><startdate>20221114</startdate><enddate>20221114</enddate><creator>Lazarovits, Gilad</creator><creator>Gefen, Orit</creator><creator>Cahanian, Noga</creator><creator>Adler, Karen</creator><creator>Fluss, Ronen</creator><creator>Levin-Reisman, Irit</creator><creator>Ronin, Irine</creator><creator>Motro, Yair</creator><creator>Moran-Gilad, Jacob</creator><creator>Balaban, Nathalie Q</creator><creator>Strahilevitz, Jacob</creator><general>Oxford University Press</general><scope>TOX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221114</creationdate><title>Prevalence of Antibiotic Tolerance and Risk for Reinfection Among Escherichia coli Bloodstream Isolates: A Prospective Cohort Study</title><author>Lazarovits, Gilad ; Gefen, Orit ; Cahanian, Noga ; Adler, Karen ; Fluss, Ronen ; Levin-Reisman, Irit ; Ronin, Irine ; Motro, Yair ; Moran-Gilad, Jacob ; Balaban, Nathalie Q ; Strahilevitz, Jacob</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-fd0eee7b44d08ba4cdcedc2ed7fe8fc9a0bacaa186ee16c9971633eb344a7f783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Bacteremia - microbiology</topic><topic>Escherichia coli</topic><topic>Escherichia coli Infections - drug therapy</topic><topic>Humans</topic><topic>Prevalence</topic><topic>Prospective Studies</topic><topic>Reinfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lazarovits, Gilad</creatorcontrib><creatorcontrib>Gefen, Orit</creatorcontrib><creatorcontrib>Cahanian, Noga</creatorcontrib><creatorcontrib>Adler, Karen</creatorcontrib><creatorcontrib>Fluss, Ronen</creatorcontrib><creatorcontrib>Levin-Reisman, Irit</creatorcontrib><creatorcontrib>Ronin, Irine</creatorcontrib><creatorcontrib>Motro, Yair</creatorcontrib><creatorcontrib>Moran-Gilad, Jacob</creatorcontrib><creatorcontrib>Balaban, Nathalie Q</creatorcontrib><creatorcontrib>Strahilevitz, Jacob</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lazarovits, Gilad</au><au>Gefen, Orit</au><au>Cahanian, Noga</au><au>Adler, Karen</au><au>Fluss, Ronen</au><au>Levin-Reisman, Irit</au><au>Ronin, Irine</au><au>Motro, Yair</au><au>Moran-Gilad, Jacob</au><au>Balaban, Nathalie Q</au><au>Strahilevitz, Jacob</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of Antibiotic Tolerance and Risk for Reinfection Among Escherichia coli Bloodstream Isolates: A Prospective Cohort Study</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clin Infect Dis</addtitle><date>2022-11-14</date><risdate>2022</risdate><volume>75</volume><issue>10</issue><spage>1706</spage><epage>1713</epage><pages>1706-1713</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>Abstract
Background
Tolerance is the ability of bacteria to survive transient exposure to high concentrations of a bactericidal antibiotic without a change in the minimal inhibitory concentration, thereby limiting the efficacy of antimicrobials. The study sought to determine the prevalence of tolerance in a prospective cohort of E. coli bloodstream infection and to explore the association of tolerance with reinfection risk.
Methods
Tolerance, determined by the Tolerance Disk Test (TDtest), was tested in a prospective cohort of consecutive patient-unique E. coli bloodstream isolates and a collection of strains from patients who had recurrent blood cultures with E. coli (cohorts 1 and 2, respectively). Selected isolates were further analyzed using time-dependent killing and typed using whole-genome sequencing. Covariate data were retrieved from electronic medical records. The association between tolerance and reinfection was assessed by the Cox proportional-hazards regression and a Poisson regression models.
Results
In cohort 1, 8/94 isolates (8.5%) were tolerant. Using multivariate analysis, it was determined that the risk for reinfection in the patients with tolerant index bacteremia was significantly higher than for patients with a nontolerant strain, hazard ratio, 3.98 (95% confidence interval, 1.32–12.01). The prevalence of tolerance among cohort 2 was higher than in cohort 1, 6/21(28.6%) vs 8/94 (8.5%), respectively (P = .02).
Conclusions
Tolerant E. coli are frequently encountered among bloodstream isolates and are associated with an increased risk of reinfection. The TDtest appears to be a practicable approach for tolerance detection and could improve future patient management.
Tolerance may lead to the failure of antibiotic therapy. Applying the Tolerance Disk Test, we found that 8.5% of Escherichia coli bloodstream infections were tolerant, tolerant strains were more frequent among patients with recurrent bacteremia, and tolerance was an independent risk for reinfection.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>35451002</pmid><doi>10.1093/cid/ciac281</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1058-4838 |
ispartof | Clinical infectious diseases, 2022-11, Vol.75 (10), p.1706-1713 |
issn | 1058-4838 1537-6591 |
language | eng |
recordid | cdi_crossref_primary_10_1093_cid_ciac281 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Bacteremia - microbiology Escherichia coli Escherichia coli Infections - drug therapy Humans Prevalence Prospective Studies Reinfection |
title | Prevalence of Antibiotic Tolerance and Risk for Reinfection Among Escherichia coli Bloodstream Isolates: A Prospective Cohort Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T21%3A24%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20Antibiotic%20Tolerance%20and%20Risk%20for%20Reinfection%20Among%20Escherichia%20coli%20Bloodstream%20Isolates:%20A%20Prospective%20Cohort%20Study&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Lazarovits,%20Gilad&rft.date=2022-11-14&rft.volume=75&rft.issue=10&rft.spage=1706&rft.epage=1713&rft.pages=1706-1713&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1093/cid/ciac281&rft_dat=%3Coup_cross%3E10.1093/cid/ciac281%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/35451002&rft_oup_id=10.1093/cid/ciac281&rfr_iscdi=true |